2020 IPO

Schrodinger Stock

Computational drug design

Sign up today and learn more about Schrodinger Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Bill & Melinda Gates Foundation


New York NY, US

Total Funding


About Schrodinger Stock

Schrödinger is a scientific developer of computational drug design for pharmaceutical and biotechnology research.


Funding History

April 2010$10.0M
December 2012$20.0M
June 2015$22.0M
January 2019$85.0M


Chief Biomedical Scientist

Karen Akinsanya

Chief Financial Officer

Joel Lebowitz

Chief Business Officer

Cony D'Cruz


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: